An integrative online self-help program (Deprexis®) versus waitlist control for adults with depressive symptoms

An integrative online self-help program (Deprexis®) versus waitlist control for adults with depressive symptoms: a randomised parallel group controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN64953693

Enrollment

200

Registered

2009-04-22

Start date

2007-02-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive symptoms Mental and Behavioural Disorders Depressive episode

Interventions

The Deprexis® program consists of ten interactive modules, plus one introductory and one summary module, which can be completed at the users own speed and frequency during a period of nine weeks. The

instead, users navigate through the program by choosing from various response options that are continuously presented to them. The program is delivered via the internet and is protected by individuall

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older, either sex 2. Indicate agreement with an electronic consent form

Exclusion criteria

Exclusion criteria: Does not meet with inclusion criteria

Design outcomes

Primary

Measure	Time frame
Depressive symptom level, measured with the German version of the Beck Depression Inventory (BDI). For both the initial treatment group and the control (delayed treatment) group, data were collected at baseline, 9 weeks and 18 weeks. Additionally, participants in the control group completed questionnaires 9 weeks after completing the program (for those in the initial treatment group, this 9-week post-treatment timepoint coincided with the 18-week assessment point mentioned above). Both groups also completed questionnaires 6 months after their respective program usage termination.	—

Measure

Time frame

Depressive symptom level, measured with the German version of the Beck Depression Inventory (BDI). For both the initial treatment group and the control (delayed treatment) group, data were collected at baseline, 9 weeks and 18 weeks. Additionally, participants in the control group completed questionnaires 9 weeks after completing the program (for those in the initial treatment group, this 9-week post-treatment timepoint coincided with the 18-week assessment point mentioned above). Both groups also completed questionnaires 6 months after their respective program usage termination.

—

Secondary

Measure	Time frame
1. Work and Social Adjustment Scale (German translation) 2. Subjective usefulness of the program, as measured by individually designed items For both the initial treatment group and the control (delayed treatment) group, data were collected at baseline, 9 weeks and 18 weeks. Additionally, participants in the control group completed questionnaires 9 weeks after completing the program (for those in the initial treatment group, this 9-week post-treatment timepoint coincided with the 18-week assessment point mentioned above). Both groups also completed questionnaires 6 months after their respective program usage termination.	—

Measure

Time frame

1. Work and Social Adjustment Scale (German translation) 2. Subjective usefulness of the program, as measured by individually designed items For both the initial treatment group and the control (delayed treatment) group, data were collected at baseline, 9 weeks and 18 weeks. Additionally, participants in the control group completed questionnaires 9 weeks after completing the program (for those in the initial treatment group, this 9-week post-treatment timepoint coincided with the 18-week assessment point mentioned above). Both groups also completed questionnaires 6 months after their respective program usage termination.

—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026